Johnson & Johnson (JNJ) Net Margin (2009 - 2026)

Johnson & Johnson has disclosed Net Margin across 18 years of filings, most recently posting 21.86% for Q2 2026.

• In Q2 2026, Net Margin fell 146.0% year-over-year to 21.86%; the TTM figure through Jun 2026 stood at 21.48% (down 352.0% YoY), while the FY2025 annual figure was 28.46%, up 1262.0% from the prior year.
• Net Margin came in at 21.86% for Q2 2026 at Johnson & Johnson, roughly flat from 21.76% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 121.91% in Q4 2023 to a low of 0.33% in Q2 2023.
• Average Net Margin over 5 years is 26.27%, with a median of 21.61% recorded in 2025.
• Year-over-year, Net Margin jumped 9961 bps in 2023 and sank 10992 bps in 2024.
• Over 5 years, Net Margin stood at 22.29% in 2022, then decreased by 15 bps to 18.92% in 2023, then declined by 19 bps to 15.24% in 2024, then surged by 37 bps to 20.83% in 2025, then rose by 5 bps to 21.86% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 21.86% in Q2 2026, 21.76% in Q1 2026, and 20.83% in Q4 2025.